Unknown

Dataset Information

0

Correlations of disease severity outcome measures in inclusion body myositis.


ABSTRACT: This study aimed to evaluate the correlation between various outcome measures used to assess disease severity and progression in inclusion body myositis (IBM) clinical trials. A cross-sectional study, involving 51 IBM patients meeting the European Neuromuscular Center (ENMC) 2011 criteria for clinically defined or probable IBM, was completed at the University of California, Irvine. Clinical details, demographic data, and functional data including timed get up (TGU), manual muscle testing, hand grip, pinch dynamometry, as well as IBM functional rating scale (IBMFRS), modified Rankin score, forced vital capacity (FVC), and modified ocular bulbar facial respiratory scale (mOBFRS) were collected on all patients. Descriptive statistics and Pearson's r correlation were performed to analyze the data. Age of the patient did not correlate with any of the outcome measures. Greater severity of IBMFRS scores correlated with longer disease duration as well as greater severity for FVC, strength outcomes, TGU, modified Rankin, and mOBFRS. Additionally, TGU strongly correlated with muscle strength measurements, modified Rankin, and mOBFRS. mOBFRS moderately correlated with IBMFRS, muscle strength, FVC, TGU and modified Rankin score. We demonstrate moderate to strong correlations among the disease severity outcome measures in this study.

SUBMITTER: Goyal NA 

PROVIDER: S-EPMC10069380 | biostudies-literature | 2022 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Correlations of disease severity outcome measures in inclusion body myositis.

Goyal Namita A NA   Greenberg Steven A SA   Cauchi Jonathan J   Araujo Nadia N   Li Vivian V   Wencel Marie M   Irani Tyler T   Wang Leo H LH   Palma Anton M AM   Villalta S Armando SA   Mozaffar Tahseen T  

Neuromuscular disorders : NMD 20220824 10


This study aimed to evaluate the correlation between various outcome measures used to assess disease severity and progression in inclusion body myositis (IBM) clinical trials. A cross-sectional study, involving 51 IBM patients meeting the European Neuromuscular Center (ENMC) 2011 criteria for clinically defined or probable IBM, was completed at the University of California, Irvine. Clinical details, demographic data, and functional data including timed get up (TGU), manual muscle testing, hand g  ...[more]

Similar Datasets

2014-02-02 | E-MTAB-2141 | biostudies-arrayexpress
| S-EPMC4196838 | biostudies-other
| S-EPMC9645777 | biostudies-literature
| S-EPMC9472875 | biostudies-literature
| S-EPMC2780610 | biostudies-literature
2021-07-01 | GSE151758 | GEO
| S-EPMC4233319 | biostudies-literature
| S-EPMC4590682 | biostudies-other
| S-EPMC5043094 | biostudies-literature
| S-EPMC9071572 | biostudies-literature